Cargando…
Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient
Background: Histogram indices (HIs) and texture features (TFs) are considered to play an important role in future oncologic PET-imaging and it is unknown how these indices are affected by changes of tracer doses. A randomized undersampling of PET list mode data enables a simulation of tracer dose re...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611106/ https://www.ncbi.nlm.nih.gov/pubmed/37888735 http://dx.doi.org/10.3390/tomography9050143 |
_version_ | 1785128413741187072 |
---|---|
author | Vogel, Jonas Seith, Ferdinand Estler, Arne Nikolaou, Konstantin Schmidt, Holger la Fougère, Christian Küstner, Thomas |
author_facet | Vogel, Jonas Seith, Ferdinand Estler, Arne Nikolaou, Konstantin Schmidt, Holger la Fougère, Christian Küstner, Thomas |
author_sort | Vogel, Jonas |
collection | PubMed |
description | Background: Histogram indices (HIs) and texture features (TFs) are considered to play an important role in future oncologic PET-imaging and it is unknown how these indices are affected by changes of tracer doses. A randomized undersampling of PET list mode data enables a simulation of tracer dose reduction. We performed a phantom study to compare HIs/TFs of simulated and measured tracer dose reductions and evaluated changes of HIs/TFs in the liver of patients with PETs from simulated reduced tracer doses. Overall, 42 HIs/TFs were evaluated in a NEMA phantom at measured and simulated doses (stepwise reduction of [18 F] from 100% to 25% of the measured dose). [18 F]-FDG-PET datasets of 15 patients were simulated from 3.0 down to 0.5 MBq/kgBW in intervals of 0.25 MBq/kgBW. HIs/TFs were calculated from two VOIs placed in physiological tissue of the right and left liver lobe and linear correlations and coefficients of variation analysis were performed. Results: All 42 TFs did not differ significantly in measured and simulated doses (p > 0.05). Also, 40 TFs showed the same behaviour over dose reduction regarding differences in the same group (measured or simulated), and for 26 TFs a linear behaviour over dose reduction for measured and simulated doses could be validated. Out of these, 13 TFs could be identified, which showed a linear change in TF value in both the NEMA phantom and patient data and therefore should maintain the same informative value when transferred in a dose reduction setting. Out of this Homogeneity 2, Entropy and Zone size non-uniformity are of special interest because they have been described as preferentially considerable for tumour heterogeneity characterization. Conclusions: We could show that there was no significant difference of measured and simulated HIs/TFs in the phantom study and most TFs reveal a linear behaviour over dose reduction, when tested in homogeneous tissue. This indicates that texture analysis in PET might be robust to dose modulations. |
format | Online Article Text |
id | pubmed-10611106 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106111062023-10-28 Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient Vogel, Jonas Seith, Ferdinand Estler, Arne Nikolaou, Konstantin Schmidt, Holger la Fougère, Christian Küstner, Thomas Tomography Article Background: Histogram indices (HIs) and texture features (TFs) are considered to play an important role in future oncologic PET-imaging and it is unknown how these indices are affected by changes of tracer doses. A randomized undersampling of PET list mode data enables a simulation of tracer dose reduction. We performed a phantom study to compare HIs/TFs of simulated and measured tracer dose reductions and evaluated changes of HIs/TFs in the liver of patients with PETs from simulated reduced tracer doses. Overall, 42 HIs/TFs were evaluated in a NEMA phantom at measured and simulated doses (stepwise reduction of [18 F] from 100% to 25% of the measured dose). [18 F]-FDG-PET datasets of 15 patients were simulated from 3.0 down to 0.5 MBq/kgBW in intervals of 0.25 MBq/kgBW. HIs/TFs were calculated from two VOIs placed in physiological tissue of the right and left liver lobe and linear correlations and coefficients of variation analysis were performed. Results: All 42 TFs did not differ significantly in measured and simulated doses (p > 0.05). Also, 40 TFs showed the same behaviour over dose reduction regarding differences in the same group (measured or simulated), and for 26 TFs a linear behaviour over dose reduction for measured and simulated doses could be validated. Out of these, 13 TFs could be identified, which showed a linear change in TF value in both the NEMA phantom and patient data and therefore should maintain the same informative value when transferred in a dose reduction setting. Out of this Homogeneity 2, Entropy and Zone size non-uniformity are of special interest because they have been described as preferentially considerable for tumour heterogeneity characterization. Conclusions: We could show that there was no significant difference of measured and simulated HIs/TFs in the phantom study and most TFs reveal a linear behaviour over dose reduction, when tested in homogeneous tissue. This indicates that texture analysis in PET might be robust to dose modulations. MDPI 2023-09-27 /pmc/articles/PMC10611106/ /pubmed/37888735 http://dx.doi.org/10.3390/tomography9050143 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Vogel, Jonas Seith, Ferdinand Estler, Arne Nikolaou, Konstantin Schmidt, Holger la Fougère, Christian Küstner, Thomas Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient |
title | Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient |
title_full | Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient |
title_fullStr | Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient |
title_full_unstemmed | Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient |
title_short | Impact of Tracer Dose Reduction in [18 F]-Labelled Fluorodeoxyglucose-Positron Emission Tomography ([18 F]-FDG)-PET) on Texture Features and Histogram Indices: A Study in Homogeneous Tissues of Phantom and Patient |
title_sort | impact of tracer dose reduction in [18 f]-labelled fluorodeoxyglucose-positron emission tomography ([18 f]-fdg)-pet) on texture features and histogram indices: a study in homogeneous tissues of phantom and patient |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611106/ https://www.ncbi.nlm.nih.gov/pubmed/37888735 http://dx.doi.org/10.3390/tomography9050143 |
work_keys_str_mv | AT vogeljonas impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient AT seithferdinand impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient AT estlerarne impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient AT nikolaoukonstantin impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient AT schmidtholger impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient AT lafougerechristian impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient AT kustnerthomas impactoftracerdosereductionin18flabelledfluorodeoxyglucosepositronemissiontomography18ffdgpetontexturefeaturesandhistogramindicesastudyinhomogeneoustissuesofphantomandpatient |